Intraoperative autotransfusion of whole blood was performed using the Solcotrans device in 45 patients undergoing major vascular surgery or other procedures in which there was a clean operative field. Overall, 60% of the blood shed during these operations was reinfused. Approximately 50% of patients avoided the potential complications of homologous transfusion. There were no complications attributable to the use of this device although in a sample of 13 patients, 30% of the erythrocytes were haemolysed and there were other minor haematological abnormalities. In conclusion this device provides a simple method of autotransfusing 2 or 3 litres of blood aspirated from an uncontaminated operative field.
AachR.D., SumnessW., MoseleyJ.W.Serum alanine aminotransferase of donors in relation to the risk of nonA nonB hepatitis in recipients. N Eng J Med1981; 304: 989–94
VoogtP.J., CornelisJ.H., van de Velde, BrandA., HermansJ., StijnenT., BloemR.Perioperative blood transfusion and cancer prognosis. Cancer1987; 59: 836–43
4.
KoretzR.L., GitnickG.L.Prevention of post transfusion hepatitis. The role of sensitive hepatitis B antigen screening test, source of blood and volume of transfusion. Am J Med1975; 59: 754–60
5.
SurgenorD.M.Editorial. The patient's blood is the safest blood. W Eng J Med1987; 316: 542–44
6.
DaleR.F., LindopM.J., FarmanJ.V., SmithM.F.Autotransfusion, an experience of seventy six cases. Ann R Coll Surg1986; 68: 295–7
7.
Council on Scientific Affairs. American Medical Association autologous blood transfusions. JAMA1986; 256: 2378–80
